View on web

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 28   •   Issue 5   •   January 30, 2025

The study's authors found "no evidence that the allocation of cannabis retailer licenses led to changes in cannabis-related ED visits."

"CBD administration did not affect any of the dependent variables measured compared to the placebo group," investigators concluded.

Ohio: GOP Lawmakers Move To Roll Back State’s Voter-Approved Marijuana Legalization Law  1/30/25

Colorado Springs: City Council Seeks To Overturn Election Outcome With New Marijuana Repeal Question  1/29/25

NORML Is Standing Up for Your Rights  1/29/25

Maryland: Annapolis City Council Members Vote to End Marijuana Testing for Public Employees  1/28/25

Join NORML for 2025 and Stand for Cannabis Freedom  1/23/25

"Individuals receiving cannabis treatment exhibited substantially higher rates of clinical remission at eight weeks compared to those in the control group," researchers concluded.

TAKE ACTION: Marijuana-related bills have been introduced in multiple states

The patient's symptoms continued to improve throughout the trial period, resulting in a reduction in his use of prescription medicines.

LEARN: These states are the most likely to enact significant marijuana reforms in 2025

ACTIVISM: NORML Chapter holds annual lobby day in Richmond

PENNSYLVANIA: Marijuana legalization debates heat up in Harrisburg: Here's what's on the table

VIRGINIA: Lawmakers advance marijuana record-sealing bill, reject effort to expand police search powers